Evidence map›Paper›PMID 36284314›Full record

ArticleBMC medicine2022

Neutrophil degranulation and severely impaired extracellular trap formation at the basis of susceptibility to infections of hemodialysis patients.

Salti Talal, Khoury Mona, Awad Karem, Lerenthal Yaniv, Harari-Misgav Reut, Shemesh Ariel, Avraham-Kelbert Moran, Eitam Harel, Salvatore Campisi-Pinto, Abu-Amna Mahmoud and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Salti TalalOncology & Hematology Division, Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel.
Khoury MonaOncology & Hematology Division, Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel.
Awad KaremNephrology Department, Emek Medical Center, Afula, Israel.
Lerenthal YanivCannasoul Analytics Ltd, Caesarea, Israel.
Harari-Misgav ReutCannasoul Analytics Ltd, Caesarea, Israel.
Shemesh ArielBiomedical Core Facility, Bruce Rappaport Faculty of Medicine Technion-Israel, Haifa, Israel.
Avraham-Kelbert MoranEmek Medical Center, Clinical Laboratories, Clalit, Afula, Israel.
Eitam HarelEmek Medical Center, Clinical Laboratories, Clalit, Afula, Israel.
Salvatore Campisi-PintoEmek Medical Center, Research Authority, Afula, Israel.
Abu-Amna MahmoudOncology & Hematology Division, Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel.
Colodner RaulEmek Medical Center, Clinical Laboratories, Clalit, Afula, Israel.
Tovbin DavidNephrology Department, Emek Medical Center, Afula, Israel.
Bar-Sela GilOncology & Hematology Division, Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel. gil_ba@clalit.org.il.ORCID http://orcid.org/0000-0001-6579-1841
Cohen IdanOncology & Hematology Division, Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel. idan5161@gmail.com.ORCID https://orcid.org/0000-0001-6933-9385
Emek Medical Center · ILTechnion – Israel Institute of Technology · ILRappaport Family Institute for Research in the Medical Sciences · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease patients are at increased risk of mortality with cardiovascular diseases and infections as the two leading causes of death for end-stage kidney disease treated with hemodialysis (HD). Mortality from bacterial infections in HD patients is estimated to be 100-1000 times higher than in the healthy population.

methodsWe comprehensively characterized highly pure circulating neutrophils from HD and healthy donors.

resultsProtein levels and transcriptome of HD patients' neutrophils indicated massive neutrophil degranulation with a dramatic reduction in reactive oxygen species (ROS) production during an oxidative burst and defective oxidative cellular signaling. Moreover, HD neutrophils exhibit severely impaired ability to generate extracellular NET formation (NETosis) in NADPH oxidase-dependent or independent pathways, reflecting their loss of capacity to kill extracellular bacteria. Ectopic hydrogen peroxidase (H

conclusionsOur report is one of the first singular examples of severe and chronic impairment of NET formation leading to substantial clinical susceptibility to bacteremia that most likely results from the metabolic and environmental milieu typical to HD patients and not by common human genetic deficiencies. In this manner, aberrant gene expression and differential exocytosis of distinct granule populations could reflect the chronic defect in neutrophil functionality and their diminished ability to induce NETosis. Therefore, our findings suggest that targeting NETosis in HD patients may reduce infections, minimize their severity, and decrease the mortality rate from infections in this patient population.

Indexed as

Extracellular TrapsExocytosisHumansHydrogenHydrogen PeroxideNADPH OxidasesNeutrophilsPeroxidasesReactive Oxygen SpeciesRenal DialysisHydrogenHydrogen PeroxideNADPH OxidasesPeroxidasesReactive Oxygen SpeciesHemodialysisInfectionsNeutrophil degranulationNeutrophil extracellular traps (NETosis)Neutrophils

Identifiers

PMID36284314
PMCPMC9597999
OpenAlexW4307380032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.